Skip to Content

Notice

Manufacturer of Controlled Substances Registration: Noramco, Inc.

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of registration.

SUMMARY:

Noramco, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Noramco, Inc. registration as a manufacturer of those controlled substances.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

By notice dated September 26, 2014, and published in the Federal Register on October 7, 2014, 79 FR 60498, Noramco, Inc., Olympic Drive, Athens, Georgia 30601 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice.

The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed:

Controlled substanceSchedule
Gamma Hydroxybutyric Acid (2010)I
Codeine-N-oxide (9053)I
Dihydromorphine (9145)I
Morphine-N-oxide (9307)I
Amphetamine (1100)II
Methylphenidate (1724)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Hydrocodone (9193)II
Morphine (9300)II
Oripavine (9330)II
Thebaine (9333)II
Opium tincture (9630)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Alfentanil (9737)II
Sufentanil (9740)II
Carfentanil (9743)II
Tapentadol (9780)II
Fentanyl (9801)II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Start Signature

Dated: June 25, 2015.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2015-16455 Filed 7-2-15; 8:45 am]

BILLING CODE 4410-09-P